Japan’s Medical Costs Down ¥16.3 Billion Due To Generic Promotion
This article was originally published in PharmAsia News
Medical expenses in Japan decreased an estimated ¥16.3 billion between 2009 and 2012 thanks to the promotion of generic drug use, according to a Japan Health Insurance Association fiscal report announced July 9.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.